Evaluation of the efficacy of daikenchuto (TJ-100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial

Tsutomu Fujii,Seiko Hirono,Satoshi Morita,Naru Kondo,Hidetoshi Eguchi,Jiro Ohuchida,Yasuhiro Kodera,Masayuki Sho,Yoshiyuki Nakajima,Sohei Satoi,Manabu Kawai,Hiroaki Nagano,Yasuhiro Shimizu,Yoshiyasu Ambo,Junichi Sakamoto,Yoshiaki Murakami,A‐Hon Kwon ,Mari S Oba ,Ken-Ichi Okada ,Hiroki Yamaue

doi:10.1016/j.pan.2016.05.138

Evaluation of the efficacy of daikenchuto (TJ-100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial

Tsutomu Fujii, Seiko Hirono + Show 18 more

https://doi.org/10.1016/j.pan.2016.05.138

Copy DOI

Journal: Pancreatology

Publication Date: Jun 1, 2016

Affiliation: Nagoya University, Wakayama Medical University, Kyoto University, Hiroshima University, Osaka University, University of Miyazaki, Nara Medical University, Kansai Medical University, Aichi Cancer Center, Teine Keijinkai Hospital, Tokai Central Hospital, Yokohama City University Medical Center, Yokohama City University

#Placebo-controlled Trial #Efficacy Of Daikenchuto + Show 1 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Evaluation of the efficacy of daikenchuto (TJ-100) for the prevention of paralytic ileus after pancreaticoduodenectomy: A multicenter, double-blind, randomized, placebo-controlled trial

Full Text

Paper version not known

Open DOI Link

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Pancreatology

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.